Pharmacists’ knowledge, support, and perceived roles associated with providing naloxone in the community

Stewart, Brittany; Thomas, Ronald; Tutag-Lehr, Victoria

doi:10.1016/j.cptl.2018.05.016

Cited by 14 publications

(10 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Overall, respondents were evenly split between males and females Study sample sizes and response rates were varied; 3 studies had response rates below 10%. [26][27][28] Five studies measured pharmacists' attitudes toward naloxone dispensing, 23,24,[26][27][28] 1 study investigated attitudes toward naloxone, buprenorphine, and buprenorphine/naloxone, 29 and 1 study examined attitudes toward buprenorphine/naloxone only. 25 No studies were found reporting of pharmacists' attitudes toward methadone or naltrexone dispensing.…”

Section: Resultsmentioning

confidence: 99%

“…Stewart et al reported that approximately 50% of respondents had supportive attitudes to providing naloxone counseling, and 56% believed that they had a responsibility to follow up with patients receiving naloxone. 27 However, only 2% of respondents have provided naloxone to patients without a prescription. Significant predictors of pharmacists' follow-up with patients were pharmacists practicing in a rural setting, agreement to naloxone availability without a prescription, and having prior naloxone education.…”

Section: Pharmacists' Attitudes Toward Naloxone Dispensingmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacists’ Attitudes toward Dispensing Naloxone and Medications for Opioid Use Disorder: A Scoping Review of the Literature

et al. 2019

View full text Add to dashboard Cite

Background Pharmacists are on the frontline caring for patients at risk of an opioid overdose and for patients with an opioid use disorder (OUD). Dispensing naloxone and medications for OUD and counseling patients about these medications are ways pharmacists can provide care. Key to pharmacists’ involvement is their willingness to take on these practice responsibilities. Methods The purpose of this scoping review is to identify, evaluate, and summarize published literature describing pharmacists’ attitudes toward naloxone and medications for OUD, i.e., methadone, buprenorphine, and naltrexone. All searches were performed on December 7, 2018, in 5 databases: Embase.com , PubMed.gov , Cumulative Index to Nursing and Allied Health Literature (CINAHL) via EBSCOhost, Cochrane Central Register of Controlled Trials via Wiley, and Clarivate Web of Science. Articles included original research conducted in the United States, described attitude-related language toward naloxone and medications for OUD, and pharmacists. Results A total of 1323 articles were retrieved, 7 were included. Five studies reported on pharmacists’ attitudes toward naloxone dispensing, 1 study reported on attitudes toward naloxone, buprenorphine, and buprenorphine/naloxone, and 1 reported on attitudes toward buprenorphine/naloxone. Respondents were diverse, including pharmacists from different practice specialties. Studies found that pharmacists agreed with a naloxone standing order, believed that naloxone should be dispensed to individuals at risk of an opioid overdose, and were supportive of dispensing buprenorphine. A minority of pharmacists expressed negative attitudes. Barriers cited to implementation included education and training, workflow, and management support. Conclusions Pharmacists were positive in their attitudes toward increased practice responsibilities for patients at risk of an opioid overdose or with an OUD. Pharmacists must receive education and training to be current in their understanding of OUD medications, and they must be supported in order to provide effective care to this patient population.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Pharmacists' Attitudes Toward Naloxone Dispensingmentioning

confidence: 99%

Pharmacists’ Attitudes toward Dispensing Naloxone and Medications for Opioid Use Disorder: A Scoping Review of the Literature

et al. 2019

View full text Add to dashboard Cite

show abstract

“…This high level of baseline naloxone knowledge is consistent with that seen in previous research in recent years. 51 The area of least knowledge amongst participants was the duration of action of naloxone. Pharmacists were also less knowledgeable about the intramuscular vial and PFS dosage forms versus the single-step nasal spray (Narcan) despite their lower cost to the patient, indicating that these may be key areas for academicians and researchers to focus future educational programs and interventions.…”

Section: Discussionmentioning

confidence: 99%

Impact of a Multicomponent Educational Intervention on Community Pharmacy–Based Naloxone Services Implementation: A Pragmatic Randomized Controlled Trial

et al. 2022

View full text Add to dashboard Cite

Background: Despite US naloxone access laws, community pharmacists lack training and confidence in providing naloxone. Objective: To assess the impact of the Empowering Community Pharmacists program on pharmacists’ knowledge, perceived barriers, attitudes, confidence, and intentions regarding naloxone services implementation, as well as naloxone prescriptions dispensed. Methods: A 3-month pragmatic randomized controlled trial was conducted from December 2018 to March 2019. Alabama community pharmacists were recruited by mail, email, phone, and fax and randomized to intervention (monthly resources/reminders + educational webinar) or control (monthly reminders only). Outcome measures were assessed via online surveys at baseline (T1), immediately post-intervention (T2), and 3 months post-intervention (T3), including naloxone knowledge (%correct); perceived barriers, attitudes, confidence, and intention regarding naloxone services implementation (7-point Likert-type scale; 1 = strongly disagree, 7 = strongly agree); and number of naloxone prescriptions dispensed. Mean differences between control and intervention from T1 to T3 were assessed using 2-way mixed analysis of variance and adjusted analyses were conducted using generalized estimating equations with negative binomial distribution to assess associations between variables. Results: Of 55 participants (n = 27 intervention, n = 28 control), most were female (80.3%), white (80.6%), in independently owned pharmacies (39.1%). Increases in mean [SD] confidence (5.52 [1.03]-6.16 [0.74], P < 0.0005) and intention (5.35 [1.51]-6.10 [0.96], P = 0.023) occurred from pre- to post-program within the intervention group and were statistically significant compared with control (confidence P = 0.016, intention P = 0.014). Confidence (exp(β) = 1.46, P = 0.031) and perceived barriers (exp(β) = 0.75, P = 0.022) were associated with number of naloxone prescriptions dispensed. Conclusion and Relevance: The Empowering Community Pharmacists program improved community pharmacists’ confidence and intention regarding naloxone services implementation. Other states can adapt program elements according to their laws. ClinicalTrials.gov Identifier: NCT05093309

show abstract

“…degree have a clear advantage in a hospital setting, in which they contribute to patient care in medical floors and critical care units (Anderson, & Marrs, 2018;Basri et al, 2018;Moore, & Kenworthy, 2017), B.Sc. holders are also required to have independent and critical roles in inpatient and outpatients pharmacies (Stewart, Thomas, & Tutag-Lehr, 2018 (ACPE, 2015). ACPE also provides insights on the optimal settings for APPEs to be conducted efficiently.…”

Section: Introductionmentioning

confidence: 99%

Developing advanced hospital pharmacy practice experiences in a Bachelor of Pharmacy programme in Jordan: A novel training programme and evaluation of student perceptions

et al. 2021

View full text Add to dashboard Cite

Objective: To describe, introduce, and assess student perceptions of a structured clinical training programme for pharmacy students that meets the expectations of advanced pharmacy practice experiences of Doctor of Pharmacy (Pharm.D.) programmes accredited by the Accreditation Council for Pharmacy Education. Methods: A clinical training programme was held from July to September 2019. Training included hands-on hospital rotations focusing on essential pillars of pharmaceutical care including ensuring proper medical indication, effectiveness, safety, and patient adherence (total of 160 hours). The study population included 35 senior pharmacy students from the University of Petra. Results: Qualitative answers from students showed positive responses associated with the programme’s pre-training orientation, clinical training, preceptors involved, and student’s clinical knowledge and skills. Conclusion: The piloted introduction of a structured clinical training programme for pharmacy students was successful. Students reported positive evaluations and perceptions of clinical training sites and staff as well as their clinical and practical skills. The main challenge students encountered was transportation to the practice site.

show abstract

Pharmacists’ knowledge, support, and perceived roles associated with providing naloxone in the community

Cited by 14 publications

References 15 publications

Pharmacists’ Attitudes toward Dispensing Naloxone and Medications for Opioid Use Disorder: A Scoping Review of the Literature

Pharmacists’ Attitudes toward Dispensing Naloxone and Medications for Opioid Use Disorder: A Scoping Review of the Literature

Impact of a Multicomponent Educational Intervention on Community Pharmacy–Based Naloxone Services Implementation: A Pragmatic Randomized Controlled Trial

Developing advanced hospital pharmacy practice experiences in a Bachelor of Pharmacy programme in Jordan: A novel training programme and evaluation of student perceptions

Contact Info

Product

Resources

About